55 related articles for article (PubMed ID: 23121773)
1. Using the Dynamic Well-Stirred Model to Extrapolate Hepatic Clearance of Organic Anion-Transporting Polypeptide Transporter Substrates without Assuming Albumin-Mediated Hepatic Drug Uptake.
Yan Z; Ma L; Hwang N; Huang J; Kenny JR; Hop CECA
Drug Metab Dispos; 2024 May; 52(6):548-554. PubMed ID: 38604729
[TBL] [Abstract][Full Text] [Related]
2. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug-drug interactions.
Armani S; Geier A; Forst T; Merle U; Alpers DH; Lunnon MW
Br J Clin Pharmacol; 2024 Apr; 90(4):942-958. PubMed ID: 38148609
[TBL] [Abstract][Full Text] [Related]
3. Humanization of
Rysz M; Schäfer AM; Paloumpis N; Kinzi J; Brecht K; Seibert I; Schmidlin S; In-Albon K; Ricklin D; Meyer Zu Schwabedissen HE
J Pharmacol Exp Ther; 2024 Mar; 389(1):87-95. PubMed ID: 38448247
[TBL] [Abstract][Full Text] [Related]
4. The Use of Carboxyfluorescein Reveals the Transport Function of MCT6/SLC16A5 Associated with CD147 as a Chloride-Sensitive Organic Anion Transporter in Mammalian Cells.
Sugiyama K; Shimano H; Takahashi M; Shimura Y; Shimura A; Furuya T; Tomabechi R; Shirasaka Y; Higuchi K; Kishimoto H; Inoue K
J Pharm Sci; 2024 Apr; 113(4):1113-1120. PubMed ID: 38160712
[TBL] [Abstract][Full Text] [Related]
5. Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors.
Garrison DA; Talebi Z; Eisenmann ED; Sparreboom A; Baker SD
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32916864
[TBL] [Abstract][Full Text] [Related]
6. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1.
van de Steeg E; Greupink R; Schreurs M; Nooijen IH; Verhoeckx KC; Hanemaaijer R; Ripken D; Monshouwer M; Vlaming ML; DeGroot J; Verwei M; Russel FG; Huisman MT; Wortelboer HM
Drug Metab Dispos; 2013 Mar; 41(3):592-601. PubMed ID: 23248200
[TBL] [Abstract][Full Text] [Related]
8. Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1.
Nies AT; Niemi M; Burk O; Winter S; Zanger UM; Stieger B; Schwab M; Schaeffeler E
Genome Med; 2013; 5(1):1. PubMed ID: 23311897
[TBL] [Abstract][Full Text] [Related]
9. Biological Distribution after Oral Administration of Radioiodine-Labeled Acetaminophen to Estimate Gastrointestinal Absorption Function via OATPs, OATs, and/or MRPs.
Sato K; Mizutani A; Muranaka Y; Yao J; Kobayashi M; Yamazaki K; Nishii R; Nishi K; Nakanishi T; Tamai I; Kawai K
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839818
[TBL] [Abstract][Full Text] [Related]
10. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients.
Marie S; Frost KL; Hau RK; Martinez-Guerrero L; Izu JM; Myers CM; Wright SH; Cherrington NJ
Acta Pharm Sin B; 2023 Jan; 13(1):1-28. PubMed ID: 36815037
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rb1 and Rd Remarkably Inhibited the Hepatic Uptake of Ophiopogonin D in Shenmai Injection Mediated by OATPs/oatps.
Liu X; Chen L; Liu M; Zhang H; Huang S; Xiong Y; Xia C
Front Pharmacol; 2018; 9():957. PubMed ID: 30186179
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese Volunteers.
Takehara I; Terashima H; Nakayama T; Yoshikado T; Yoshida M; Furihata K; Watanabe N; Maeda K; Ando O; Sugiyama Y; Kusuhara H
Pharm Res; 2017 Aug; 34(8):1601-1614. PubMed ID: 28550384
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the
Kim CO; Oh ES; Kim H; Park MS
Drug Des Devel Ther; 2017; 11():503-512. PubMed ID: 28260863
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Uptake Mechanism of Ophiopogonin D Mediated by Organic Anion Transporting Polypeptides.
Zhang W; Xiong X; Chen L; Liu M; Xiong Y; Zhang H; Huang S; Xia C
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):669-676. PubMed ID: 27815731
[TBL] [Abstract][Full Text] [Related]
15. Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System.
El-Kattan AF; Varma MV; Steyn SJ; Scott DO; Maurer TS; Bergman A
Pharm Res; 2016 Dec; 33(12):3021-3030. PubMed ID: 27620173
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.
Daniels MA; Kan C; Willmes DM; Ismail K; Pistrosch F; Hopkins D; Mingrone G; Bornstein SR; Birkenfeld AL
Pharmacogenomics J; 2016 Oct; 16(5):399-410. PubMed ID: 27432533
[TBL] [Abstract][Full Text] [Related]
17. The influence of oral antidiabetic drugs on cellular drug uptake mediated by hepatic OATP family members.
Klatt S; Fromm MF; König J
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):244-50. PubMed ID: 23121773
[TBL] [Abstract][Full Text] [Related]
18. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
